Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00059540 · ClinicalTrials.gov registry record
The Maternal Lifestyle Study (MLS)
A clinical trial, sponsored by NICHD Neonatal Research Network.
- Completed
- Registry status
- 11,811
- Enrollment target
NCT00059540: Completed study, sponsored by NICHD Neonatal Research Network.
NCT00059540 is a clinical trial that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 11,811 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00059540 has completed, sponsored by NICHD Neonatal Research Network.
- COMPLETED
- Registry status
- 11,811 participants
- Enrollment target
Study Summary
This is a longitudinal, multi-site observational study of the long-term effects of a mother's use of cocaine and/or opiates during pregnancy on her infant. This observational study evaluates the medical, developmental, social, environmental, and neurobehavioral outcomes for 1,400 of the original cohort of children. A series of follow-up examinations of these children were conducted in 5 phases: 1-36 months, 3.5-7 years, and 8-11 years. Children are currently being examined at 13 years of age.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,811 participants |
| Start Date | 1993-05 |
| Est. Completion | 2011-03 |
What the finished NCT00059540 record still lists
NCT00059540 is an observational study that tracks outcomes without assigning an intervention. Its 11,811 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00059540 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00059540 about?
NCT00059540 is a clinical study titled "The Maternal Lifestyle Study (MLS)". This is a longitudinal, multi-site observational study of the long-term effects of a mother's use of cocaine and/or opiates during pregnancy on her infant. This observational study evaluates the medical, developmental, social, environmental, and neurobehavioral outcomes for 1,400 of the original coh...
What is the current status of trial NCT00059540?
This trial is currently completed. The enrollment target is 11,811 participants. The study started on 1993-05. Estimated completion is 2011-03.
Who is sponsoring clinical trial NCT00059540?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07064473 · 11,800 participants · Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia